📰 Active Biotech News
Active Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Active Biotech. Real-time updates on events, politics, business and more.
August 31, 2023
/PRNewswire/ -- The "Sunitinib Malate Market Share, Size, Trends, Industry Analysis Report, By Application, By Region, Segment Forecast, 2023-2032" report has...
April 25, 2023
/PRNewswire/ -- Immunovia AB (publ), reg. no. 556730-4299, hereby gives notice that the Annual General Meeting ("AGM") will take place on Friday 26th May 2023...
October 28, 2022
/PRNewswire/ -- The "Kidney Cancer Drugs Market, by Therapy, by Pharmacological Class, by Distribution Channel, and by Region - Size, Share, Outlook, and...
October 13, 2022
Dublin, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The "Kidney Cancer Drugs Market, by Therapy, by Pharmacological Class, by Distribution Channel, and by Region -...
September 22, 2022
The Business Research Company’s Kidney Cancer Drugs Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026
September 15, 2022
Trading in Active Biotech AB paid subscription shares is to cease. The last trading day is September 19, 2022. Short name: ACTI BTA --------------------------- ISIN code: SE0018397895 --------------------------- Orderbook
August 18, 2022
With effect from August 22, 2022, the subscription rights in Nasdaq will be traded on the list for Equity rights. Trading will continue up until and including August 31, 2022. Instrument: Subscription
August 10, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global kidney cancer drugs market is estimated to be valued at US$ 5.83 billion in 2022 and is...
July 5, 2022
NeoTX, whose team includes several Nobel laureates, is testing a cancer-fighting approach that uses bacteria to bait the immune system into an attack.
May 19, 2022
Investegate announcements from Active Biotech, Annual General Meeting of Active Biotech AB